In Vitro Biology
Our Assay Technology Team implements new technology to develop, optimize and validate a large variety of assays on GPCRs, kinases, NHRs, metabolic enzymes, epigenetic enzymes, ligand-gated ion channels, and transporters. This team focuses on executing HTS campaigns for our clients.
We apply state-of-the-art technologies including FLIPR, HTRF, alpha screen, radiometry, FACS, LC/MS, and nanoliter liquid handling to the assays, and we continually expand and deepen our capabilities. We have recently added full HTS automation and label-free technology into our high technology in order to align ourselves with the full specifications and needs of our pharma partners. Robust assay data reproducibility, problem-solving skills, adaptability to clients’ research needs are some of the unique strengths of ChemPartner.
Our Drug Discovery Team works closely with chemistry, biology, pharmacology, ADME/PK/PD and toxicology colleagues in collaborative project teams, discovering and advancing compounds, for our pharma and biotech partners from Hit-to-Lead, Lead-Optimization, and early-stage development programs. ChemPartner is committed to conducting research with the same scientific rigor and sense of urgency as our biopharmaceutical partners.